Want to see BTCY full AI Analyst Report?
Biotricity (BTCY) Financial Statements
Biotricity Financial Overview
Biotricity's market cap is currently $1.20M. The company's EPS TTM is $-0.13; its P/E ratio is -0.42; Biotricity is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Jun 25 | Mar 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 16.00M | $ 13.79M | $ 12.06M | $ 9.64M | $ 7.65M |
| Gross Profit | $ 12.95M | $ 10.56M | $ 8.36M | $ 5.44M | $ 4.57M |
| Operating Income | $ 1.69M | $ -2.45M | $ -8.83M | $ -15.41M | $ -16.74M |
| EBITDA | $ 2.44M | $ -3.21M | $ -6.73M | $ -16.07M | $ -18.56M |
| Net Income | $ -2.40M | $ -8.42M | $ -14.09M | $ -18.66M | $ -29.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 149.79K | $ 365.14K | $ 786.06K | $ 570.46K | $ 12.07M |
| Total Assets | $ 6.45M | $ 5.64M | $ 5.94M | $ 6.51M | $ 16.68M |
| Total Debt | $ 27.06M | $ 26.09M | $ 23.88M | $ 19.55M | $ 15.35M |
| Net Debt | $ 26.91M | $ 25.73M | $ 23.09M | $ 18.98M | $ 3.29M |
| Total Liabilities | $ 39.41M | $ 35.66M | $ 35.92M | $ 26.36M | $ 18.82M |
| Stockholders' Equity | $ -32.96M | $ -30.01M | $ -29.98M | $ -19.85M | $ -2.14M |
| Cash Flow | |||||
| Free Cash Flow | $ -718.96K | $ -2.38M | $ -6.69M | $ -13.55M | $ -15.19M |
| Operating Cash Flow | $ -718.96K | $ -2.38M | $ -6.69M | $ -13.55M | $ -15.16M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -29.77K |
| Financing Cash Flow | $ 557.74K | $ 1.93M | $ 6.74M | $ 2.00M | $ 25.17M |
Currency in USD